Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN118526 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Alanyl (Membrane) Aminopeptidase (ANPEP) antibody
- Antibody type
- Monoclonal
- Description
- Affinity Chromatography on Protein G
- Reactivity
- Human, Simian
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- WM15
- Vial size
- 0.1 mg
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Multiplexed mAbs: a new strategy in preclinical time-domain imaging of acute myeloid leukemia.
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.
Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
CD13/APN regulates endothelial invasion and filopodia formation.
Clinical significance of aminopeptidase N in non-small cell lung cancer.
CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated.
Myeloid progenitor surface antigen identified by monoclonal antibody.
McCormack E, Mujić M, Osdal T, Bruserud Ø, Gjertsen BT
Blood 2013 Feb 14;121(7):e34-42
Blood 2013 Feb 14;121(7):e34-42
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.
Tavernier E, Boiron JM, Huguet F, Bradstock K, Vey N, Kovacsovics T, Delannoy A, Fegueux N, Fenaux P, Stamatoullas A, Tournilhac O, Buzyn A, Reman O, Charrin C, Boucheix C, Gabert J, Lhéritier V, Vernant JP, Dombret H, Thomas X, GET-LALA Group., Swiss Group for Clinical Cancer Research SAKK., Australasian Leukaemia and Lymphoma Group.
Leukemia 2007 Sep;21(9):1907-14
Leukemia 2007 Sep;21(9):1907-14
Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Terauchi M, Kajiyama H, Shibata K, Ino K, Nawa A, Mizutani S, Kikkawa F
BMC cancer 2007 Jul 27;7:140
BMC cancer 2007 Jul 27;7:140
CD13/APN regulates endothelial invasion and filopodia formation.
Petrovic N, Schacke W, Gahagan JR, O'Conor CA, Winnicka B, Conway RE, Mina-Osorio P, Shapiro LH
Blood 2007 Jul 1;110(1):142-50
Blood 2007 Jul 1;110(1):142-50
Clinical significance of aminopeptidase N in non-small cell lung cancer.
Tokuhara T, Hattori N, Ishida H, Hirai T, Higashiyama M, Kodama K, Miyake M
Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Jul 1;12(13):3971-8
Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Jul 1;12(13):3971-8
CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated.
Favaloro EJ, Browning T, Facey D
Experimental hematology 1993 Dec;21(13):1695-701
Experimental hematology 1993 Dec;21(13):1695-701
Myeloid progenitor surface antigen identified by monoclonal antibody.
Bradstock KF, Favaloro EJ, Kabral A, Kerr A, Hughes WG, Musgrove E
British journal of haematology 1985 Sep;61(1):11-20
British journal of haematology 1985 Sep;61(1):11-20
No comments: Submit comment
No validations: Submit validation data